Skip to content

Analysis of the effect of repetitive transcranial magnetic stimulation in the treatment of tinnitus in the temporal lobe and DLPFC

Analysis of the effect of repetitive transcranial magnetic stimulation in the treatment of tinnitus in the temporal lobe and DLPFC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085901
Enrollment
Unknown
Registered
2024-06-20
Start date
2023-11-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus

Interventions

rtms group of combination :rtms in DLPFC and temporal lobe
rtms group of temporal lobe:rtms in temporal lobe

Sponsors

Shanghai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: tinnitus group (1) age=18 and <80 years old ,no gender limit; (2) subjective tinnitus; (3) Chronic tinnitus, lasting = 6 months; (4) The subject or his/her legal representative is able to understand the purpose of the study and sign the informed consent form. NC (1) age=18 and <80 years old ,no gender limit; (2)without tinnitus; (4)The subject or his/her legal representative is able to understand the purpose of the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: tinnitus group (1) Objective tinnitus; (2)patients with metal implants, ; (3) history of pilepsy, brain organic diseases, brain trauma and head surgery (4) heart disease, infections and tumors or ear diseases that may cause tinnitus such as Meniere's disease; (5) hearing allergies, anxiety, depression and other mental diseases; (6) Have received other tinnitus treatment measures within one month, or are currently participating in other research projects that may affect tinnitus; NC (1) doenot meet the inclusion criteria; (2)patients with metal implants, ; (3) history of pilepsy, brain organic diseases, brain trauma and head surgery (4) heart disease, infections and tumors or ear diseases that may cause tinnitus such as Meniere's disease; (5) hearing allergies, anxiety, depression and other mental diseases; (6) Have received other tinnitus treatment measures within one month, or are currently participating in other research projects that may affect tinnitus;

Design outcomes

Secondary

MeasureTime frame
VAS;electroencephalogram, EEG;Beck Depression Inventory, BDI;self-rating anxiety scale, SAS;pittsburgh sleep quality index, PSQI;

Primary

MeasureTime frame
tinnitus matching test;

Countries

China

Contacts

Public ContactWang Hui

Shanghai Sixth People’s Hospital

wangh2014@163.com+86 189 3017 0537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026